[Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].
作者信息
Cosín J, Gimeno J V, Martín G, Ramírez A, Ferrer J, Báguena J
出版信息
Rev Esp Cardiol. 1982;35(5 Suppl 2):II115-22.
PMID:7170402
Abstract
摘要
相似文献
1
[Calcium-antagonist-type cardiac effects of nifedipine in vitro and in vivo. Comparative experimental study].[硝苯地平在体外和体内的钙拮抗剂类心脏效应。比较实验研究]
Rev Esp Cardiol. 1982;35(5 Suppl 2):II115-22.
2
3
4
Differential cardiovascular effects of calcium channel blocking agents: potential mechanisms.钙通道阻滞剂的不同心血管效应：潜在机制
Am J Cardiol. 1982 Feb 18;49(3):499-506. doi: 10.1016/s0002-9149(82)80002-7.
5
[Electrophysiologic effects of nifedipine in humans. Comparison with verapamil].
Rev Esp Cardiol. 1982;35(5 Suppl 2):II1-5.
6
Cardiac action of KB-944, a new calcium antagonist.
Arzneimittelforschung. 1982;32(9):1053-5.
7
Calcium-channel blocking agents.钙通道阻滞剂
Clin Pharm. 1982 Jan-Feb;1(1):17-33.
8
Differences in the cardiac actions of the calcium antagonists verapamil and nifedipine.钙拮抗剂维拉帕米和硝苯地平在心脏作用方面的差异。
Arzneimittelforschung. 1976;26(7):1330-3.
9
Calcium-antagonist effects of norbormide on isolated perfused heart and cardiac myocytes of guinea-pig: a comparison with verapamil.去甲溴敌隆对豚鼠离体灌注心脏和心肌细胞的钙拮抗剂作用：与维拉帕米的比较。
Br J Pharmacol. 1997 Jan;120(1):19-24. doi: 10.1038/sj.bjp.0700876.
10
[Ventricular arrhythmias following coronary reperfusion. Comparative study of the effects of verapamil and nifedipine].
Arq Bras Cardiol. 1982 Mar;38(3):187-91.
Zotero 插件